A study to determine adverse event following immunization using COVISHIELD vaccine for prevention of COVID-19 infection in a field practice area of urban health center
DOI:
https://doi.org/10.3126/ajms.v13i6.44474Keywords:
AEFIs of COVID-19 vaccine, COVID-19 vaccination, COVISHIELDAbstract
Background: The COVID-19 vaccination program was introduced in India on 16 January 2021. The Government-issued fact sheet was the only source of information regarding Adverse Events Following Immunizations (AEFIs) for these vaccines.
Aims and Objectives: The objective of this study was to assess the AEFI reported following COVISHIELD vaccination in an urban health center.
Materials and Methods: The spontaneous reporting method was used for data collection for 3 months. A data collection form was designed to collect the data from the study population who reported adverse events. Collected data were analyzed and categorized by severity and seriousness. The causality assessment was done using the World Health Organization’s causality assessment algorithm.
Results: A total of 3,486 doses of COVISHIELD vaccine were administered at the study site during the study period. In all, 306 AEFIs were reported from 190 subjects with an incidence rate of 5.45%. The majority of the subjects with AEFIs belonged to the age group of 18–45 years. Out of the total 306 AEFIs, 287 AEFIs were expected as per the fact sheets. Most of the AEFIs (59.47% [n=182]) were observed at the system organ class of “General disorders and administration site conditions.” After the causality assessment, out of 433 AEFIs to COVISHIELD vaccine, 94.22% (n=287) of events were categorized to have “consistent causal association with immunization.” All of them recovered from their adverse events without any sequelae.
Conclusion: Most common AEFI after COVISHIELD vaccination was found to be general disorders and administration site conditions. No severe AEFI reported.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).